Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune...
8 insider purchases on record · latest filing 2024-02-12.
Insiders have also filed 31 sale transactions at SANA.